Gabapentin Tablet
Product Images NDC 68788-7774

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68788-7774). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin 800mg 500tab

This is a description of Gabapentin tablets 800mg manufactured by ScieGen Pharmaceuticals, Inc. It is a generic version of Neurontin. Each tablet contains 800mg of gabapentin. The tablets are shipped in a package with expiry dates and lot numbers. The tablets should be stored at room temperature and kept out of reach of children. The tablets are white, scored, and imprinted with 178 /S G. It is a controlled substance and can only be taken by the patient it is prescribed for. The rest of the text is not available.*

FDA Label Image

Figure 1 (Image 01)

This appears to be a chart or table with headings "Mean Pain Score", "0", "4", "Work Dose Tiration", "Parkod", "Week Fixed Dose Period", "O-Placebo", "# Gabapentin, 3600 mg/day", "Baseline", and "Weeks". It is not clear what the context or purpose of the chart is.*

FDA Label Image

Figure 2 (Image 02)

FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Cockcroft And Gault Equation (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.